Colonial River Investments’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$561K Buy
11,652
+712
+7% +$33.2K 0.2% 101
2025
Q4
$530K Buy
10,940
+537
+5% +$26.6K 0.19% 118
2025
Q3
$491K Buy
10,403
+1,789
+21% +$86.3K 0.18% 126
2025
Q2
$425K Buy
8,614
+2,617
+44% +$134K 0.18% 123
2025
Q1
$333K Buy
+5,997
New +$325K 0.18% 120
2023
Q3
Sell
-11,026
Closed -$594K 175
2023
Q2
$594K Buy
+11,026
New +$593K 0.39% 75

Other funds holding SNY

Colonial River Investments's SNY Position: Q1 2026 in Review

Colonial River Investments increased its Sanofi (SNY) stake by 6.5% in Q1 2026, buying an estimated $33.2K and bringing the position to 11,652 shares worth $561K. The position accounts for 0.2% of the portfolio, ranked #101.

Colonial River Investments first reported a position in SNY in Q2 2023 and has held it in 6 quarters since. The position peaked at $594K in Q2 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Colonial River Investments held 11,652 shares of Sanofi worth $561K as of Q1 2026.
  • Colonial River Investments bought 712 Sanofi shares in Q1 2026, an estimated $33.2K.
  • Sanofi made up 0.2% of Colonial River Investments's portfolio in Q1 2026, its #101 holding.
  • Colonial River Investments first reported a position in Sanofi in Q2 2023 and has held it in 6 quarters since.
  • Colonial River Investments's Sanofi position peaked at $594K in Q2 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Colonial River Investments's 13F filing for Q1 2026, filed 27 Apr 2026.